2024-03-28T18:05:46Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_876B680C2B0D
2024-03-23T02:38:36Z
serval:BIB_876B680C2B0D
Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment.
10.1007/s00213-009-1608-2
19652957
000269381000014
Urigüen
L.
author
García-Fuster
M.J.
author
Callado
L.F.
author
Morentin
B.
author
La Harpe
R.
author
Casadó
V.
author
Lluis
C.
author
Franco
R.
author
García-Sevilla
J.A.
author
Meana
J.J.
author
article
2009
Psychopharmacology
1432-2072
0033-3158
journal
206
2
313-324
Adult
Aged
Analysis of Variance
Antipsychotic Agents/pharmacology
Antipsychotic Agents/therapeutic use
Female
Frontal Lobe/drug effects
Gene Expression Regulation/drug effects
Gene Expression Regulation/genetics
Humans
Male
Middle Aged
Postmortem Changes
RNA, Messenger/metabolism
Receptor, Adenosine A2A/genetics
Receptor, Adenosine A2A/metabolism
Receptor, Cannabinoid, CB1/genetics
Receptor, Cannabinoid, CB1/metabolism
Receptors, Dopamine D2/genetics
Receptors, Dopamine D2/metabolism
Schizophrenia/drug therapy
Schizophrenia/metabolism
Suicide/psychology
Young Adult
eng
60_published
peer-reviewed
Publication types: Journal Article ; Research Support, Non-U.S. Gov't Publication Status: ppublish